Inside the $15b hostile battle pitting Pfizer against Novo

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.
News Tribune

Brittle bones aren’t just a woman’s problem

Ronald Klein was biking around his neighborhood in North Wales, Pennsylvania, in 2006 and tried to jump a curb.

Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk

Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...
The Autopian on MSN

Mitsubishi’s Twin-Stick Was The Best Solution For An Incredibly Strange Gearbox Setup

The oil crises of the 1970s undoubtedly reshaped the direction of automotive history. The demand for more fuel-efficient ...